Want to join the conversation?
$MLHR expects net sales in 2Q17 to be $580-600MM. On an organic basis, adjusted for the impact of a dealer divestiture, this forecast implies sales growth of approx. 2.5% over 2Q16 at the mid-point of the range. Diluted EPS is expected to be $0.52-0.56.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?